Veracyte Q1 Revenues Rise 70 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Veractye's first quarter revenues increased 70 percent year over year, the molecular cytology firm announced after the close of the market on Thursday.

The South San Francisco, Calif.-based company said that for the three months ended March 31, revenues rose to $7.5 million from $4.4 million in the year-ago quarter as it received 14,373 fine need aspiration samples during the recently completed quarter, compared to 10,757 in the first quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.